Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 3 | 2019 | 708 | 1.030 |
Why?
|
| Fathers | 1 | 2024 | 71 | 0.910 |
Why?
|
| B-Lymphocytes | 5 | 2019 | 1345 | 0.820 |
Why?
|
| Genital Neoplasms, Male | 1 | 2021 | 45 | 0.760 |
Why?
|
| Scrotum | 1 | 2021 | 57 | 0.750 |
Why?
|
| Oximes | 1 | 2021 | 179 | 0.690 |
Why?
|
| Immune Tolerance | 2 | 2021 | 409 | 0.670 |
Why?
|
| Transplantation | 1 | 2017 | 53 | 0.590 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2019 | 829 | 0.560 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2017 | 242 | 0.540 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2016 | 267 | 0.500 |
Why?
|
| Imidazoles | 1 | 2021 | 1035 | 0.490 |
Why?
|
| Macrophages | 1 | 2019 | 1326 | 0.420 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 919 | 0.400 |
Why?
|
| Mice, Inbred NOD | 5 | 2019 | 893 | 0.350 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2019 | 1803 | 0.330 |
Why?
|
| Leukocyte Common Antigens | 2 | 2021 | 187 | 0.320 |
Why?
|
| Paternal Age | 1 | 2024 | 12 | 0.240 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 1026 | 0.240 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 4696 | 0.240 |
Why?
|
| Melanoma | 1 | 2021 | 5344 | 0.230 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2023 | 39 | 0.230 |
Why?
|
| Erectile Dysfunction | 1 | 2023 | 215 | 0.190 |
Why?
|
| Antimetabolites | 1 | 2021 | 72 | 0.190 |
Why?
|
| Deoxyglucose | 1 | 2021 | 117 | 0.190 |
Why?
|
| Urinary Bladder Diseases | 1 | 2021 | 50 | 0.190 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily A | 1 | 2019 | 4 | 0.170 |
Why?
|
| Adoptive Transfer | 2 | 2019 | 425 | 0.170 |
Why?
|
| Sarcopenia | 1 | 2020 | 112 | 0.160 |
Why?
|
| CD8 Antigens | 1 | 2019 | 170 | 0.160 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 247 | 0.160 |
Why?
|
| Meningomyelocele | 1 | 2021 | 179 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 6791 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 14438 | 0.150 |
Why?
|
| Interleukin-15 | 1 | 2019 | 184 | 0.150 |
Why?
|
| Islets of Langerhans | 1 | 2019 | 221 | 0.150 |
Why?
|
| Oncogenes | 1 | 2021 | 672 | 0.150 |
Why?
|
| Metformin | 1 | 2021 | 389 | 0.150 |
Why?
|
| Immunoglobulin M | 1 | 2018 | 337 | 0.140 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 595 | 0.140 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2016 | 36 | 0.140 |
Why?
|
| Receptors, Transferrin | 1 | 2015 | 40 | 0.130 |
Why?
|
| Poly I-C | 1 | 2015 | 29 | 0.130 |
Why?
|
| Erythroid Cells | 1 | 2015 | 51 | 0.130 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2015 | 25 | 0.130 |
Why?
|
| Imatinib Mesylate | 1 | 2019 | 1686 | 0.120 |
Why?
|
| Allografts | 1 | 2016 | 672 | 0.120 |
Why?
|
| Osteoblasts | 1 | 2016 | 383 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 7039 | 0.110 |
Why?
|
| Mice | 7 | 2021 | 34706 | 0.110 |
Why?
|
| Animals | 8 | 2021 | 59528 | 0.110 |
Why?
|
| Flow Cytometry | 2 | 2016 | 2999 | 0.110 |
Why?
|
| Kidney | 1 | 2021 | 2136 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 7269 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2019 | 5669 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 932 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2019 | 5454 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2015 | 1380 | 0.090 |
Why?
|
| Sepsis | 1 | 2015 | 656 | 0.080 |
Why?
|
| Aged | 3 | 2024 | 71287 | 0.080 |
Why?
|
| Obesity | 1 | 2020 | 2907 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2015 | 1204 | 0.080 |
Why?
|
| Male | 6 | 2024 | 124154 | 0.070 |
Why?
|
| United States | 1 | 2024 | 15693 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 1055 | 0.070 |
Why?
|
| Antibodies | 2 | 2021 | 787 | 0.060 |
Why?
|
| Humans | 7 | 2024 | 262697 | 0.060 |
Why?
|
| Penile Erection | 1 | 2023 | 82 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 5822 | 0.060 |
Why?
|
| Transplantation Tolerance | 1 | 2021 | 18 | 0.050 |
Why?
|
| Glycosylation | 1 | 2021 | 213 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 265 | 0.040 |
Why?
|
| Middle Aged | 2 | 2024 | 87462 | 0.040 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2019 | 3 | 0.040 |
Why?
|
| Glycolysis | 1 | 2021 | 524 | 0.040 |
Why?
|
| Adult | 1 | 2024 | 78789 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 164 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2023 | 12960 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2019 | 262 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2019 | 335 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2020 | 709 | 0.030 |
Why?
|
| Reticulocytes | 1 | 2015 | 50 | 0.030 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2020 | 466 | 0.030 |
Why?
|
| CD11b Antigen | 1 | 2015 | 64 | 0.030 |
Why?
|
| Endotoxins | 1 | 2015 | 92 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 2911 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 95 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 1108 | 0.030 |
Why?
|
| Female | 4 | 2021 | 143767 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 1275 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 1432 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 3302 | 0.030 |
Why?
|
| Spleen | 1 | 2015 | 681 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2015 | 469 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 1826 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 5206 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 38842 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12268 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 7204 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 13777 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 7588 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 30243 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 11940 | 0.010 |
Why?
|